Highlights of ASH in Asia-Pacific
Registration is now open!
Join the world's leading hematology experts at Highlights of ASH in Asia-Pacific, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and non-malignant hematology.
February 22-23, 2025
PACIFICO Yokohama | Yokohama, Japan
About Highlights of ASH in Asia-Pacific
By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.
Through participation in this meeting, you will be able to:
Access a program curated from highlights of the ASH annual meeting which covers the latest and most influential topics in hematology.
Engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.
This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.
Program Co-Host
ASH is proud to co-host this meeting with the Japanese Society of Hematology.
Program Co-Chairs
The Program Co-Chairs for the Highlights of ASH in Asia-Pacific are:
- Japanese Society of Hematology Program Co-Chairs
- Dr. Akifumi Takaori-Kondo
- Dr. Kinuko Mitani
- American Society of Hematology Program Co-Chairs
- Dr. Jonathan Kaufman
- Dr. Jia Ruan
Program Schedule
The following session topics correspond to the 2025 Highlights of ASH in Asia-Pacific and is subject to change.
| 8:00 a.m. | Registration and Exhibits Open | |
| 8:30 a.m. | Welcome & Introduction | |
| 8:45 a.m. | Highlights in Aggressive Lymphoma Nancy Bartlett, MD Washington University St. Louis, Missouri |
|
| 9:15 a.m. | Highlights in Indolent Lymphoma and Chronic Lymphocytic Leukemia Jia Ruan, MD, PhD Weill Cornell Medicine New York, New York |
|
| 9:45 a.m. | Panel Discussion | |
| 10:15 a.m. | Coffee Break in the Exhibit Hall | |
| 10:45 a.m. | Special Education Session: T-Cell Lymphoma Moderator: Mamiko Sakata-Yanagimoto, MD, PhD University of Tsukuba Tsukuba, Japan |
|
| T-Cell Lymphoma Won Seog Kim, MD, PhD Samsung Medical Center Seoul, South Korea |
||
|
Basic T-Cell Lymphoma Keisuke Kataoka, MD, PhD Keio University Tokyo, Japan |
||
|
Clinical T-Cell Lymphoma Dai Maruyama, MD, PhD Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo, Japan |
||
| 12:00 p.m. | Panel Discussion | |
| 12:15 p.m. | Lunch with the Experts (Ticketed) Lunch in the Exhibit Hall (All Attendees) Satellite Symposia |
|
| 1:15 p.m. |
Inherited Bone Marrow Failure Syndromes Moonjung Jung, MD, MS Johns Hopkins Medicine Baltimore, Maryland |
|
| 1:45 p.m. |
Aplastic Anemia Bhumika Patel, MD Prisma Health Cancer Institute, Greenville, SC |
|
| 2:15 p.m. |
Complement-Related Diseases: Paroxysmal Nocturnal Hemoglobinuria and Autoimmune Hemolytic Anemia Christopher Patriquin, MD University of Toronto Toronto, Canada |
|
| 2:45 p.m. | Panel Discussion | |
| 3:15 p.m. | Coffee Break in the Exhibit Hall | |
| 3:45 p.m. | Special Education Session: Gene and Cell Therapy for Hematological Diseases Moderator: Takahiro Maeda, MD, PhD Kyushu University Graduate School of Medical Sciences Fukuoka, Japan |
|
| Gene and Cell Therapy for Hematological Diseases: CAR-T Nilanjan Ghosh, MD, PhD, FACP Atrium Health Levine Cancer Institute and Wake Forest School of Medicine Charlotte, North Carolina |
||
| Gene and Cell Therapy for Hematological Diseases: Gene Editing Jaap Jan Boelens, MD, PhD Memorial Sloan Kettering Cancer Center New York, New York |
||
| Next Generation Clinical Sequencing and MRD Evaluation Farhad Ravandi, MD The University of Texas MD Anderson Cancer Center Houston, Texas |
||
| 5:15 p.m. | Panel Discussion | |
| 5:45 p.m. | Highlights of ASH® Day 1 Program Adjournment | |
| 8:00 a.m. | Registration and Exhibits Open |
| 8:30 a.m. | Welcome & Introduction |
| 8:45 a.m. | Transplant Ran Reshef, MD, MSc Columbia University New York, New York |
| 9:15 a.m. | Bleeding and Platelet Disorders Jorge Di Paola, MD Washington University in St. Louis St. Louis, Missouri |
| 9:45 a.m. | Panel Discussion |
| 10:15 a.m. | Coffee Break in the Exhibit Hall |
| 10:45 a.m. | Acute Lymphoblastic Leukemia Adam Duvall, MD, MPH University of Chicago Chicago, Illinois |
| 11:15 a.m. | Acute Myeloid Leukemia Mary-Elizabeth Percival, MD University of Washington and Fred Hutchinson Cancer Center Seattle, Washington |
| 11:45 a.m. | Myeloma, MGUS, and Plasma Cell Disorders Jonathan Kaufman, MD Emory University Atlanta, Georgia |
| 12:15 p.m. | Panel Discussion |
| 12:45 p.m. | Lunch with the Experts (Ticketed) Lunch in the Exhibit Hall (All Attendees) Satellite Symposia |
| 2:00 p.m. | Hemoglobinopathies Kelly M. Davidson, MD UVA Health Charlottesville, Virginia |
| 2:30 p.m. | Thrombotic Disorders Anita Rajasekhar, MD University of Florida Gainesville, Florida |
| 3:00 p.m. | Panel Discussion |
| 3:30 p.m. | Coffee Break in the Exhibit Hall |
| 4:00 p.m. | Myeloproliferative Neoplasms including Chronic Myeloid Leukemia Jorge Cortes, MD Augusta University Augusta, Georgia |
| 4:30 p.m. | Myelodysplastic Syndromes and Clonal Hematopoiesis Guillermo Garcia-Manero, MD MD Anderson Cancer Center Houston, Texas |
| 5:00 p.m. | Panel Discussion |
| 5:30 p.m. | Highlights of ASH® Adjournment |
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission